<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="norrie" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">norrie</book-part-id>
      <title-group>
        <title>
<italic toggle="yes">NDP</italic>-Related Retinopathies</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sims</surname>
            <given-names>Katherine B</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Director, Developmental Neurogenetics Clinic<break/>Director, Neurogenetics DNA Diagnostic Lab<break/>Professor, Neurology<break/>Massachusetts General Hospital / Harvard Medical School<break/>Boston, Massachusetts</aff>
          <email>ksims@mgh.harvard.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="1999-07-30" date-type="created">
          <day>30</day>
          <month>7</month>
          <year>1999</year>
        </date>
        <date iso-8601-date="2014-09-18" date-type="updated">
          <day>18</day>
          <month>9</month>
          <year>2014</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="myotonic-d2" document-type="chapter">Myotonic Dystrophy Type 2</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="nkx2-1-dis" document-type="chapter"><italic toggle="yes">NKX2-1</italic>-Related Disorders</related-object>
      <abstract id="norrie.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">NDP</italic>-related retinopathies are characterized by a spectrum of fibrous and vascular changes of the retina at birth that progress through childhood or adolescence to cause varying degrees of visual impairment. The most severe phenotype is described as Norrie disease (ND), characterized by greyish yellow fibrovascular masses (pseudogliomas) secondary to retinal vascular dysgenesis and detachment. Congenital blindness is almost always present. Approximately 30%-50% of males with ND have developmental delay/intellectual disability, behavioral abnormalities, or psychotic-like features. The majority of males with ND develop sensorineural hearing loss. Less severe phenotypes include: persistent hyperplastic primary vitreous (PHPV), characterized by a fibrotic white stalk from the optic disk to the lens; X-linked familial exudative vitreoretinopathy (XL-FEVR), characterized by peripheral retinal vascular anomalies with or without fibrotic changes and retinal detachment; retinopathy of prematurity (ROP); and Coats disease, an exudative proliferative vasculopathy. Phenotypes can vary within families.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of <italic toggle="yes">NDP</italic>-related retinopathies relies on a combination of clinical findings and molecular genetic testing of <italic toggle="yes">NDP</italic>, which identifies pathogenic variants in approximately 95% of affected males.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Treatment for less than complete retinal detachment includes surgery and/or laser therapy with the potential for improved outcomes if done at an early age. Surgery may be required for increased intraocular pressure. Rarely, enucleation of the eye is required to control pain. Treatment for hearing loss may include hearing aids and cochlear implantation. Behavioral issues and/or cognitive impairment involve supportive intervention and therapy.</p>
          <p><italic toggle="yes">Surveillance:</italic> Routine monitoring of vision and hearing.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p><italic toggle="yes">NDP</italic>-related retinopathies are inherited in an X-linked manner. Affected males transmit the pathogenic variant to all their daughters, who will be carriers, and none of their sons. Carrier females have a 50% chance of transmitting the pathogenic variant to each child; males who inherit the pathogenic variant will be affected, and females who inherit the pathogenic variant will be carriers and will generally not be affected. Carrier testing for at-risk female relatives and prenatal testing for pregnancies at increased risk are possible if the pathogenic variant has been identified in the family.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="norrie.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="norrie.Tc" position="anchor" orientation="portrait">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_norrie.Tc_1_1_1_1" valign="top" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">NDP</italic>-Related Retinopathies: Included Phenotypes&#x000a0;<sup>1</sup></th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_norrie.Tc_1_1_1_1" valign="top" align="left" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Norrie disease (ND)</p>
                    </list-item>
                    <list-item>
                      <p>Persistent hyperplastic primary vitreous (PHPV)</p>
                    </list-item>
                    <list-item>
                      <p>X-linked familial exudative vitreoretinopathy (X-linked FEVR)</p>
                    </list-item>
                    <list-item>
                      <p><italic toggle="yes">NDP</italic>-related retinopathy of prematurity (ROP)</p>
                    </list-item>
                    <list-item>
                      <p>Coats disease</p>
                    </list-item>
                  </list>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>For synonyms and outdated names see <xref ref-type="sec" rid="norrie.Nomenclature">Nomenclature</xref>.</p>
            </fn>
            <fn id="norrie.TF.c.1">
              <label>1. </label>
              <p>For other genetic causes of these phenotypes see <xref ref-type="sec" rid="norrie.Differential_Diagnosis">Differential Diagnosis</xref>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="norrie.Diagnosis">
        <title>Diagnosis</title>
        <sec id="norrie.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>An <italic toggle="yes">NDP</italic>-related retinopathy should be suspected in individuals with the following ocular findings:</p>
          <list list-type="bullet">
            <list-item>
              <p>Congenital visual failure/blindness</p>
            </list-item>
            <list-item>
              <p>Bilateral, often symmetric involvement of the eyes</p>
            </list-item>
            <list-item>
              <p>Persistent hyperplastic primary vitreous, hyaloid vessels, shallow anterior chamber, and vitreoretinal hemorrhages. Microopthalmia and cataracts may be present.</p>
            </list-item>
            <list-item>
              <p>Presence of retrolental fibrous and vascular retinal changes at birth (leukokoria) with progressive changes through childhood or adolescence</p>
            </list-item>
          </list>
          <p>Pathogenic variants in <italic toggle="yes">NDP</italic> are associated with a spectrum of characterized retinal findings ranging from classic Norrie disease (ND) to X-linked familial exudative vitreoretinopathy (FEVR), some cases of persistent hyperplastic primary vitreous (PHPV), Coats disease, and advanced retinopathy of prematurity (ROP). These phenotypes appear to be a continuum of retinal findings with considerable overlap (<xref ref-type="table" rid="norrie.T.classification_of_ocular_phenot">Table 1</xref>).</p>
          <table-wrap id="norrie.T.classification_of_ocular_phenot" position="anchor" orientation="portrait">
            <label>Table 1. </label>
            <caption>
              <p>Classification of Ocular Phenotypes Observed in Individuals with an <italic toggle="yes">NDP</italic> Pathogenic Variant</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Phenotype</th>
                  <th id="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Ocular Findings / <break/>Age</th>
                  <th id="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Progression / <break/>Age</th>
                  <th id="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Vision</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Norrie disease (ND)</bold>
                  </td>
                  <td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Greyish-yellow fibrovascular masses ("pseudoglioma") behind the lens (i.e., retrolental), retinal detachment (frequently) / <break/>Birth &#x02013; 3 mos</td>
                  <td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Cataract, posterior synechiae (iris to lens), anterior synechiae (iris to cornea), iris atrophy, shallowing of anterior chamber, corneal opacification, band keratopathy, loss of intraocular pressure, shrinking of the globe (phthisis bulbi) / <break/>3 mos to 8-10 yrs</td>
                  <td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Light perception impaired or non-existent</td>
                </tr>
                <tr>
                  <td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Persistent hyperplastic primary vitreous (PHPV)&#x000a0;<sup>1</sup></bold>
                  </td>
                  <td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Fibrotic white stalk with hyaloid vessels extending from optic disk to posterior lens capsule / <break/>Birth</td>
                  <td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Unknown / <break/>Unknown</td>
                  <td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Varying impairment</td>
                </tr>
                <tr>
                  <td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>X-linked familial exudative vitreoretinopathy (FEVR)&#x000a0;<sup>2</sup></bold>
                  </td>
                  <td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Peripheral temporal retinal avascular zone &#x000b1; congenital retinal folds, macular ectopia, fibrous tissue band at ora serrate / <break/>Birth</td>
                  <td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x000b1; Retinal detachment (tractional and/or exudative; may be unilateral) / <break/>&#x02264; age 20 yrs</td>
                  <td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Normal to impaired</td>
                </tr>
                <tr>
                  <td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Retinopathy of prematurity (ROP) stage 4B/5&#x000a0;<sup>3</sup></bold>
                  </td>
                  <td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Retinal neovascularization, fibrous proliferation, end-stage retrolental fibroplasia /<break/>Premature birth</td>
                  <td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Partial or complete retinal detachment</td>
                  <td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Impaired to blind</td>
                </tr>
                <tr>
                  <td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Coats disease&#x000a0;<sup>4</sup></bold>
                  </td>
                  <td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Unilateral retinal telangiectasia, exudative fibrosis</td>
                  <td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Progressive vascular leakage, subretinal exudation and fibrosis, retinal detachment</td>
                  <td headers="hd_h_norrie.T.classification_of_ocular_phenot_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Normal to impaired</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="norrie.TF.1.1">
                <label>1. </label>
                <p><italic toggle="yes">NDP</italic> pathogenic variants in PHPV [<xref ref-type="bibr" rid="norrie.REF.shastry.2009a.884">Shastry 2009a</xref>]</p>
              </fn>
              <fn id="norrie.TF.1.2">
                <label>2. </label>
                <p><italic toggle="yes">NDP</italic> pathogenic variants not infrequent in clinically identified X-linked FEVR [<xref ref-type="bibr" rid="norrie.REF.nikopoulos.2010a.240">Nikopoulos et al 2010a</xref>, <xref ref-type="bibr" rid="norrie.REF.nikopoulos.2010b.656">Nikopoulos et al 2010b</xref>, <xref ref-type="bibr" rid="norrie.REF.poulter.2010.248">Poulter et al 2010</xref>, <xref ref-type="bibr" rid="norrie.REF.walsh.2011.819">Walsh et al 2011</xref>, <xref ref-type="bibr" rid="norrie.REF.yang.2012.726">Yang et al 2012</xref>].</p>
              </fn>
              <fn id="norrie.TF.1.3">
                <label>3. </label>
                <p>Rare <italic toggle="yes">NDP</italic> pathogenic variants have been seen in those with an ROP phenotype [<xref ref-type="bibr" rid="norrie.REF.shastry.1997.651">Shastry et al 1997</xref>]. Subsequent studies have identified DNA changes outside of the coding region that may be polymorphisms and/or possible modifiers of <italic toggle="yes">NDP</italic> gene expression [<xref ref-type="bibr" rid="norrie.REF.kenyon.1999.181">Kenyon &#x00026; Craig 1999</xref>, <xref ref-type="bibr" rid="norrie.REF.hiraoka.2001a.178">Hiraoka et al 2001a</xref>, <xref ref-type="bibr" rid="norrie.REF.talks.2001.e46">Talks et al 2001</xref>, <xref ref-type="bibr" rid="norrie.REF.haider.2002.365">Haider et al 2002</xref>, <xref ref-type="bibr" rid="norrie.REF.hutcheson.2005.501">Hutcheson et al 2005</xref>, <xref ref-type="bibr" rid="norrie.REF.shastry.2009b.3">Shastry 2009b</xref>].</p>
              </fn>
              <fn id="norrie.TF.1.4">
                <label>4. </label>
                <p>In a family with an <italic toggle="yes">NDP</italic> pathogenic variant, a female carrier had a mosaic phenotype (Coats disease); and her sons had classic ocular findings of ND [<xref ref-type="bibr" rid="norrie.REF.black.1999.2031">Black et al 1999</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="norrie.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of an <italic toggle="yes">NDP</italic>-related retinopathy is established in a proband with the identification of a pathogenic variant in <italic toggle="yes">NDP</italic> (see <xref ref-type="table" rid="norrie.T.summary_of_molecular_genetic_te">Table 2</xref>).</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>One genetic testing strategy</bold> is molecular genetic testing of <italic toggle="yes">NDP</italic>. Sequence analysis is performed first followed by deletion/duplication analysis if no pathogenic variant is found.</p>
            </list-item>
            <list-item>
              <p><bold>An alternative genetic testing strategy</bold> is use of a multi-gene panel that includes <italic toggle="yes">NDP</italic> and other genes of interest (see <xref ref-type="sec" rid="norrie.Differential_Diagnosis">Differential Diagnosis</xref>).Note: The genes included and the methods used in multi-gene panels vary by laboratory and over time.</p>
            </list-item>
          </list>
          <p><bold>Linkage analysis.</bold> In the very infrequent cases where a known <italic toggle="yes">NDP</italic> pathogenic variant is not identified, linkage analysis can be considered in families with more than one affected family member. Linkage studies are based on accurate clinical diagnosis of <italic toggle="yes">NDP</italic>-related retinopathies in the affected family members and accurate understanding of the genetic relationships in the family. Linkage analysis is dependent on the availability and willingness of family members to be tested. The markers used for <italic toggle="yes">NDP</italic> linkage are highly informative and very tightly linked to the <italic toggle="yes">NDP</italic> locus; thus, they can be used in many families with <italic toggle="yes">NDP</italic>-related retinopathies with greater than 95% accuracy. In informative families, linkage analysis can be used to determine the carrier status of an at-risk female.</p>
          <table-wrap id="norrie.T.summary_of_molecular_genetic_te" position="anchor" orientation="portrait">
            <label>Table 2. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in <italic toggle="yes">NDP</italic>-Related Retinopathies</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_norrie.T.summary_of_molecular_genetic_te_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_norrie.T.summary_of_molecular_genetic_te_1_1_1_1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_norrie.T.summary_of_molecular_genetic_te_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_norrie.T.summary_of_molecular_genetic_te_1_1_1_2">Test Method</th>
                  <th id="hd_h_norrie.T.summary_of_molecular_genetic_te_1_1_1_3" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th>
                </tr>
                <tr>
                  <th headers="hd_h_norrie.T.summary_of_molecular_genetic_te_1_1_1_3" id="hd_h_norrie.T.summary_of_molecular_genetic_te_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Affected Males</th>
                  <th headers="hd_h_norrie.T.summary_of_molecular_genetic_te_1_1_1_3" id="hd_h_norrie.T.summary_of_molecular_genetic_te_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Carrier Females</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_norrie.T.summary_of_molecular_genetic_te_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">NDP</italic>
                  </td>
                  <td headers="hd_h_norrie.T.summary_of_molecular_genetic_te_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_norrie.T.summary_of_molecular_genetic_te_1_1_1_3 hd_h_norrie.T.summary_of_molecular_genetic_te_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">95%&#x000a0;<sup>3,&#x000a0;4</sup></td>
                  <td headers="hd_h_norrie.T.summary_of_molecular_genetic_te_1_1_1_3 hd_h_norrie.T.summary_of_molecular_genetic_te_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">80%&#x000a0;<sup>5</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_norrie.T.summary_of_molecular_genetic_te_1_1_1_2" valign="top" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_norrie.T.summary_of_molecular_genetic_te_1_1_1_3 hd_h_norrie.T.summary_of_molecular_genetic_te_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">15%&#x000a0;<sup>7</sup></td>
                  <td headers="hd_h_norrie.T.summary_of_molecular_genetic_te_1_1_1_3 hd_h_norrie.T.summary_of_molecular_genetic_te_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">15%&#x000a0;<sup>7</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="norrie.TF.2.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="norrie" object-id="norrie.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="norrie.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="norrie.TF.2.2">
                <label>2. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="norrie.TF.2.3">
                <label>3. </label>
                <p>Lack of amplification by PCR prior to sequence analysis can suggest a putative (multi)exon or whole-gene deletion on the X chromosome in affected males; confirmation may require additional testing by deletion/duplication analysis.</p>
              </fn>
              <fn id="norrie.TF.2.4">
                <label>4. </label>
                <p>Includes the 15% of pathogenic variants that are submicroscopic deletions involving all or part of <italic toggle="yes">NDP</italic> and adjacent genomic segments [<xref ref-type="bibr" rid="norrie.REF.berger.2001">Berger &#x00026; Ropers 2001</xref>; Sims, unpublished].</p>
              </fn>
              <fn id="norrie.TF.2.5">
                <label>5. </label>
                <p>Sequence analysis of genomic DNA cannot detect deletion of one or more exons or the entire X-linked gene in a heterozygous female.</p>
              </fn>
              <fn id="norrie.TF.2.6">
                <label>6. </label>
                <p>Testing that identifies exon or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
              <fn id="norrie.TF.2.7">
                <label>7. </label>
                <p>Submicroscopic deletions involving all or part of <italic toggle="yes">NDP</italic> and adjacent genomic segments [<xref ref-type="bibr" rid="norrie.REF.berger.2001">Berger &#x00026; Ropers 2001</xref>; Sims, unpublished].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="norrie.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="norrie.Clinical_Description">
          <title>Clinical Description</title>
          <p>The ocular findings in males with an <italic toggle="yes">NDP</italic> pathogenic variant are usually bilateral and symmetric. They are present at birth and are usually progressive. The classic ND phenotype after which the disorder is named was the first described eye finding and is the best characterized of the ocular manifestations. With the discovery of <italic toggle="yes">NDP</italic> and the advent of clinically available molecular genetic testing, it has become evident that the ocular phenotypes observed in <italic toggle="yes">NDP</italic>-related retinopathies include Norrie disease (ND), persistent hyperplastic primary vitreous (PHPV), and X-linked familial exudative vitreoretinopathy (XL-FEVR), [<xref ref-type="bibr" rid="norrie.REF.riveiroalvarez.2005.705">Riveiro-Alvarez et al 2005</xref>, <xref ref-type="bibr" rid="norrie.REF.dickinson.2006.682">Dickinson et al 2006</xref>, <xref ref-type="bibr" rid="norrie.REF.kondo.2007.1276">Kondo et al 2007</xref>] (<xref ref-type="table" rid="norrie.T.classification_of_ocular_phenot">Table 1</xref>).</p>
          <p>The ocular phenotype can vary even within a family [<xref ref-type="bibr" rid="norrie.REF.berger.2001">Berger &#x00026; Ropers 2001</xref>, <xref ref-type="bibr" rid="norrie.REF.allen.2006.234">Allen et al 2006</xref>]. In one family, the spectrum of ocular phenotypes in nine affected males ranged from unilateral subtotal retinal detachment at ages three to four years that slowly progressed to a tractional detachment (at the severe end) to peripheral retinal pigmentary changes in a male age 79 years (at the mild end) [<xref ref-type="bibr" rid="norrie.REF.allen.2006.234">Allen et al 2006</xref>].</p>
          <p>
            <bold>Norrie disease</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Ocular findings.</bold> At birth, the irises, anterior chambers, cornea, intraocular pressure, and size of the globe may be normal. In newborns and infants, the classic finding is a greyish-yellow, glistening, elevated mass that replaces the retina and is visible through a clear lens. These masses are referred to as "pseudogliomas" because they resemble tumors. Partial or complete retinal detachment evolves over the first few months.From infancy throughout childhood, progressive changes typically include: opacification of the lens (cataract), atrophy of the iris with adhesions forming between the lens and the iris (posterior synechiae) and between the iris and the cornea (anterior synechiae), and development of a shallow anterior chamber with occlusion of the outflow tracts which may result in increased intraocular pressure and pain.These changes are followed by corneal opacification and band keratopathy, loss of intraocular pressure, and shrinkage of the globe (phthisis bulbi). In the end stage of ND, the corneas appear milky and opacified; and the globes appear small and sunken in the orbits [<xref ref-type="bibr" rid="norrie.REF.drenser.2007.243">Drenser et al 2007</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Cognitive/behavioral findings.</bold> Approximately 30%-50% of males with the ND phenotype have developmental delay/intellectual disability and may show poorly characterized behavioral abnormalities or psychotic-like features. Intra- and interfamilial variability in the appearance and expression of the cognitive and behavioral difficulties is common. A severe neurologic phenotype including infantile spasms has been reported [<xref ref-type="bibr" rid="norrie.REF.lev.2007.921">Lev et al 2007</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Auditory findings.</bold> The majority of males with the ND phenotype develop progressive sensorineural hearing loss starting in early childhood (<xref ref-type="fig" rid="norrie.F1">Figure 1</xref>). Onset of hearing loss can be insidious.Audiologic data suggest that the pathology resides in the cochlea (specifically, the stria vascularis) and that retrocochlear and brain auditory system function is normal. Early hearing loss is sensorineural, mild, and asymmetric. High-frequency hearing loss appears by adolescence. By age 35 years, hearing loss is severe, symmetric, and broad-spectrum. Speech discrimination is relatively well preserved even when the threshold loss is severe [<xref ref-type="bibr" rid="norrie.REF.halpin.2005.533">Halpin et al 2005</xref>, <xref ref-type="bibr" rid="norrie.REF.halpin.2008.1705">Halpin &#x00026; Sims 2008</xref>]. For most affected individuals, adaptation to the congenital blindness may be less problematic than adjustment to the later-onset, slowly progressive hearing loss.</p>
            </list-item>
            <list-item>
              <p><bold>Other.</bold> Peripheral vascular disease (<xref ref-type="fig" rid="norrie.F2">Figure 2</xref>) appears to be an associated clinical finding in a number of affected males [<xref ref-type="bibr" rid="norrie.REF.smith.2012.1909">Smith et al 2012</xref>]Pulmonary hypertension has been describedGeneral health is normal. Life span may be shortened by general risks associated with intellectual disability, blindness, and/or hearing loss, such as increased risk of trauma, aspiration pneumonia, and complications of seizure disorder.</p>
            </list-item>
          </list>
          <p><bold>PHPV</bold> is characterized by a fibrotic white stalk with vessels extending from the optic disk to the temporal posterior lens capsule. The retina may be in folds or detached; the lens may or may not be clear. Although progression to complete retinal detachment has been described, it is not clear if such progression always occurs [<xref ref-type="bibr" rid="norrie.REF.wu.2007.225">Wu et al 2007</xref>]. PHPV is usually unilateral; therefore, bilateral presentation should suggest an <italic toggle="yes">NDP</italic>-related retinopathy.</p>
          <p><bold>X-linked FEVR</bold> is characterized by premature arrest of vascularization of the retina resulting in an avascular zone in the peripheral retina. This avascular zone may be the only retinal finding, or congenital falciform retinal folds or retinal detachment may be present. When falciform folds are present, the macula may be dragged temporally (so-called macular ectopia).</p>
          <p>These eye findings may progress to retinal detachment either through increasing traction on the retina from progressive fibrovascular changes in the temporal retinal periphery or through exudation of serous fluid by the fragile capillaries in the abnormal peripheral retinal vasculature. Retinal detachment is usually accompanied by a decrease in central visual acuity because of macular involvement.</p>
          <p><bold>Advanced retinopathy of prematurity</bold>
<bold>(ROP; Stage 4B/5)</bold> involves retinal changes similar to those found in FEVR. Pathogenic variants in <italic toggle="yes">NDP</italic> were identified in four of 16 premature infants with advanced ROP [<xref ref-type="bibr" rid="norrie.REF.hiraoka.2001a.178">Hiraoka et al 2001a</xref>], raising the question of whether <italic toggle="yes">NDP</italic> pathogenic variants may predispose to the ND ocular phenotype in some premature infants. More recently in 17 infants with advanced ROP, one was identified with an <italic toggle="yes">NDP</italic> pathogenic variant in the 5&#x02019;UTR [<xref ref-type="bibr" rid="norrie.REF.hiraoka.2010.2572">Hiraoka et al 2010</xref>]. A study of 102 Kuwaiti Arab premature infants, however, identified only polymorphisms and no phenotype-associated <italic toggle="yes">NDP</italic> pathogenic variants [<xref ref-type="bibr" rid="norrie.REF.haider.2001.120">Haider et al 2001</xref>]. <xref ref-type="bibr" rid="norrie.REF.hutcheson.2005.501">Hutcheson et al [2005]</xref> studied 54 infants with severe ROP (Stage &#x02265;3) of different ethnic backgrounds and identified five sequence variations in untranslated regions (UTR) of <italic toggle="yes">NDP</italic>. No clear role for these <italic toggle="yes">NDP</italic> polymorphisms in the pathogenesis of ROP was established.</p>
          <p><bold>Coats disease</bold> (exudative retinitis) is an exudative proliferative vasculopathy with onset typically before age 20 years, and usually in infancy or childhood. Male-to-female ratio is 10:1. Retinal vascular changes include telangiectasias, venous and capillary fusiform dilatation, and microaneurysms. Subretinal lipid exudate and retinal hemorrhage are observed, usually in the macula and/or supertemporal regions. Exudative retinal detachment and decreased retinal capillary perfusion may occur. Other complications can include iridocyclitis, cataract, or neovascular glaucoma. More than 90% of reported cases appear to be unilateral.</p>
          <sec id="norrie.Histopathology">
            <title>Histopathology</title>
            <p>A retinal vasculopathy appears to be the primary pathophysiologic ocular change underlying the secondary, fibrotic reaction and associated vitreous hemorrhage. Retinal ganglion cell loss may also occur.</p>
            <p>Abnormalities of retinal vasculature have been described in the mouse model [<xref ref-type="bibr" rid="norrie.REF.richter.1998.2450">Richter et al 1998</xref>, <xref ref-type="bibr" rid="norrie.REF.sch_fer.2009.906">Sch&#x000e4;fer et al 2009</xref>]. In the ND mouse model, <xref ref-type="bibr" rid="norrie.REF.rehm.2002.4286">Rehm et al [2002]</xref> documented a progressive loss of vessels in the stria vascularis of the cochlea and an associated hearing loss. A differential gene expression study has identified candidate genes for retinal (photoreceptor) phenotype in the <italic toggle="yes">Ndp</italic> knockout mouse [<xref ref-type="bibr" rid="norrie.REF.lenzner.2002.2825">Lenzner et al 2002</xref>]. Cerebellar vascular changes have also been documented in the <italic toggle="yes">Ndph</italic> knockout mouse [<xref ref-type="bibr" rid="norrie.REF.luhmann.2008.2619">Luhmann et al 2008</xref>].</p>
          </sec>
          <sec id="norrie.Heterozygotes">
            <title>Heterozygotes</title>
            <p>In rare instances, females who are carriers may have retinal findings (retinal detachment, abnormal retinal vasculature) [<xref ref-type="bibr" rid="norrie.REF.lin.2010.93">Lin et al 2010</xref>, <xref ref-type="bibr" rid="norrie.REF.parzefall.2014.203">Parzefall et al 2014</xref>] and have been described with associated vision loss [<xref ref-type="bibr" rid="norrie.REF.yamada.2001.52">Yamada et al 2001</xref>]. A severe ocular phenotype has been described in multiple females in one family [<xref ref-type="bibr" rid="norrie.REF.khan.2008.730">Khan et al 2008</xref>].</p>
            <p>Some carrier females may show a mild sensorineural hearing loss [<xref ref-type="bibr" rid="norrie.REF.halpin.2005.533">Halpin et al 2005</xref>; Sims, unpublished data].</p>
            <p>Phenotypic expression has been reported in two females with an X;autosome translocation [<xref ref-type="bibr" rid="norrie.REF.meire.1998.203">Meire et al 1998</xref>]; however, carrier expression is usually presumed to be secondary to non-random X-chromosome inactivation and is rare.</p>
          </sec>
        </sec>
        <sec id="norrie.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Phenotypic variability, both intra- and interfamilial, has been noted in retinal phenotype [<xref ref-type="bibr" rid="norrie.REF.wu.2007.225">Wu et al 2007</xref>] and in the non-retinal clinical characteristics [<xref ref-type="bibr" rid="norrie.REF.khan.2004.361">Khan et al 2004</xref>, <xref ref-type="bibr" rid="norrie.REF.allen.2006.234">Allen et al 2006</xref>]. Intellectual disability can be variably expressed as was noted in one of two brothers with a deletion involving the <italic toggle="yes">NDP</italic> start codon [<xref ref-type="bibr" rid="norrie.REF.zhang.2013.739">Zhang et al 2013</xref>], although in other reported cases, multiple brothers evidenced classic <italic toggle="yes">NDP</italic> retinal features and all had intellectual disability [<xref ref-type="bibr" rid="norrie.REF.arai.2014.448">Arai et al 2014</xref>]. A more extended phenotype including cerebellar atrophy, movement disorder, and intellectual disability was described in three brothers and supports the hypothesis that other epigenetic factors beyond the <italic toggle="yes">NDP</italic> pathogenic variant may affect clinical phenotypic expression [<xref ref-type="bibr" rid="norrie.REF.liu.2010.2653">Liu et al 2010</xref>].</p>
          <p>Males with <italic toggle="yes">NDP</italic> deletions exhibit a more severe phenotype than those with non-deletion pathogenic variants [<xref ref-type="bibr" rid="norrie.REF.su_rezmerino.2001.523">Su&#x000e1;rez-Merino et al 2001</xref>, <xref ref-type="bibr" rid="norrie.REF.wu.2007.225">Wu et al 2007</xref>, <xref ref-type="bibr" rid="norrie.REF.yang.2012.726">Yang et al 2012</xref>, <xref ref-type="bibr" rid="norrie.REF.arai.2014.448">Arai et al 2014</xref>]. In addition to the ocular manifestations of ND, individuals with a deletion may have microcephaly, severe-to-profound intellectual disability, seizures, myoclonus, somatic growth failure, and/or delayed puberty.</p>
          <p>Pathogenic variants disrupting the cysteine-knot motif appear to correspond to severe retinal dysgenesis [<xref ref-type="bibr" rid="norrie.REF.wu.2007.225">Wu et al 2007</xref>]. Unique single-nucleotide variants, identified in four individuals with severe retinal dysplasia, affected a cysteine residue and presumably altered important structural aspects of the protein [<xref ref-type="bibr" rid="norrie.REF.drenser.2007.243">Drenser et al 2007</xref>].</p>
          <p>Although it has been suggested that pathogenic missense variants in the C-terminus region may be associated with the milder FEVR phenotype [<xref ref-type="bibr" rid="norrie.REF.allen.2006.234">Allen et al 2006</xref>], a number of individuals with severe ocular phenotypes with or without intellectual disability have had pathogenic variants in the C-terminus region [Sims, unpublished].</p>
          <p>No specific correlations have been identified between single base-pair pathogenic variants and cognitive dysfunction or hearing impairment. However, one individual with a single nucleotide variant (c.134T&#x0003e;A) has been reported with a severe neurologic phenotype including profound intellectual disability and infantile spasms [<xref ref-type="bibr" rid="norrie.REF.lev.2007.921">Lev et al 2007</xref>].</p>
          <p>Contiguous gene syndromes with more extended and variable phenotypes have been described with <italic toggle="yes">NDP</italic>+ deletion cases [<xref ref-type="bibr" rid="norrie.REF.sims.1989.1069">Sims et al 1989</xref>, <xref ref-type="bibr" rid="norrie.REF.rodriguezrevenga.2007.916">Rodriguez-Revenga et al 2007</xref>]. Familial idiopathic pulmonary hypertension was reported in a family with a Xp11.3-11.4 microdeletion including <italic toggle="yes">NDP</italic> [<xref ref-type="bibr" rid="norrie.REF.staropoli.2010.786">Staropoli et al 2010</xref>].</p>
          <p>A more extended phenotype in the affected son (cerebroretinal microangiopathy with calcifications and cysts) of a mother diagnosed with unilateral atypical Coats disease was described in association with an <italic toggle="yes">NDP</italic> pathogenic missense variant and compound heterozygous pathogenic variants in <italic toggle="yes">CTCI</italic> (conserved telomere maintenance component 1) gene [<xref ref-type="bibr" rid="norrie.REF.romaniello.2013.1702">Romaniello et al 2013</xref>] previously associated with a small-vessel obliterative microangiopathy in Coats plus [<xref ref-type="bibr" rid="norrie.REF.anderson.2012.338">Anderson et al 2012</xref>] and in cerebroretinal microangiopathy with calcifications [<xref ref-type="bibr" rid="norrie.REF.polvi.2012.540">Polvi et al 2012</xref>]. This importantly raises the question of possible pathway interactions between these two genes leading to a severe and extended phenotype both in male probands and in carrier mothers.</p>
        </sec>
        <sec id="norrie.Penetrance">
          <title>Penetrance</title>
          <p>Penetrance is complete in affected males.</p>
          <p>Rarely, a partial or mild ocular phenotype occurs in carrier females, presumably secondary to non-random X-chromosome inactivation.</p>
        </sec>
        <sec id="norrie.Nomenclature">
          <title>Nomenclature</title>
          <p>The following are outdated terms for Norrie disease:</p>
          <list list-type="bullet">
            <list-item>
              <p>Atrophia bulborum hereditaria</p>
            </list-item>
            <list-item>
              <p>Pseudoglioma</p>
            </list-item>
            <list-item>
              <p>Episkopi blindness</p>
            </list-item>
          </list>
        </sec>
        <sec id="norrie.Prevalence">
          <title>Prevalence</title>
          <p>No incidence or prevalence figures are available. <italic toggle="yes">NDP</italic> pathogenic variants were identified in 11/109 individuals with diverse pediatric vitroretinopathies [<xref ref-type="bibr" rid="norrie.REF.wu.2007.225">Wu et al 2007</xref>].</p>
          <p>Norrie disease has been reported in all ethnic groups, including northern and central European, Americans of European descent, African American, French-Canadian, Hispanic, Chinese, and Japanese. Although no ethnic group appears to predominate, most of the individuals reported in the first decades after the original description of Norrie disease were from Scandinavia.</p>
        </sec>
      </sec>
      <sec id="norrie.Genetically_Related_Allelic_Disor">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are associated with mutation of <italic toggle="yes">NDP</italic>; however, an <italic toggle="yes">NDP</italic> pathogenic variant cosegregating with an <italic toggle="yes">RS</italic> pathogenic variant has been identified in one family with <related-object link-type="booklink" source-id="gene" document-id="retinoschisis" document-type="chapter">X-linked juvenile retinoschisis</related-object> [<xref ref-type="bibr" rid="norrie.REF.hiraoka.2001b.53">Hiraoka et al 2001b</xref>] but not in other retinoschisis cases, either familial or non-familial [<xref ref-type="bibr" rid="norrie.REF.shastry.2000.627">Shastry et al 2000</xref>].</p>
      </sec>
      <sec id="norrie.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><related-object link-type="booklink" source-id="gene" document-id="retinoblastoma" document-type="chapter">Retinoblastoma</related-object> (RB) is often considered in index cases of Norrie disease (ND) if the ocular pathology is predominantly that of unilateral pseudoglioma. Because the usual presentation of ND is bilateral, diagnosis of RB is not usually a consideration. Fundoscopic examination by an ophthalmologist familiar with retinal diseases can distinguish between the two disorders.</p>
        <p>Retinal findings of ND can mimic PHPV and retinopathy of prematurity (ROP) (which occurs in preterm low birth-weight infants who have been treated with supplemental oxygen) [<xref ref-type="bibr" rid="norrie.REF.shastry.2009a.884">Shastry 2009a</xref>].</p>
        <p>Autosomal dominant familial exudative vitreoretinopathy (adFEVR) is another consideration. <italic toggle="yes">NDP</italic> is a frizzled-4 (Fzd-4) ligand and activates the canonical Wnt signaling pathway [<xref ref-type="bibr" rid="norrie.REF.xu.2004.883">Xu et al 2004</xref>, <xref ref-type="bibr" rid="norrie.REF.hendrickx.2008.229">Hendrickx &#x00026; Leyns 2008</xref>]. Pathogenic variants in <italic toggle="yes">FZD4</italic> [<xref ref-type="bibr" rid="norrie.REF.robitaille.2002.326">Robitaille et al 2002</xref>], <italic toggle="yes">LRP5</italic> [<xref ref-type="bibr" rid="norrie.REF.jiao.2004.878">Jiao et al 2004</xref>, <xref ref-type="bibr" rid="norrie.REF.toomes.2004.721">Toomes et al 2004</xref>], and <italic toggle="yes">TSPAN12</italic> [<xref ref-type="bibr" rid="norrie.REF.nikopoulos.2010b.656">Nikopoulos et al 2010b</xref>, <xref ref-type="bibr" rid="norrie.REF.poulter.2010.248">Poulter et al 2010</xref>, <xref ref-type="bibr" rid="norrie.REF.yang.2011.1128">Yang et al 2011</xref>] have been identified in <related-object link-type="booklink" source-id="gene" document-id="fevr" document-type="chapter">autosomal dominant FEVR</related-object>. Because the phenotype of FEVR may overlap with that of ND, <italic toggle="yes">FZD4, LRP5,</italic> and <italic toggle="yes">TSPAN12</italic> pathogenic variants may underlie some instances of ND in which the mode of inheritance is not clear.</p>
        <p>Retinal dysplasia with PHPV-type changes can be associated with lissencephaly in Walker-Warburg syndrome, an autosomal recessive form of congenital muscular dystrophy, and with multiple anomalies in trisomy 13. However, neither of these should be confused clinically with Norrie disease.</p>
        <p>ND is not considered in the differential diagnosis of intellectual disability and/or progressive sensorineural hearing loss (see <related-object link-type="booklink" source-id="gene" document-id="deafness-overview" document-type="chapter">Deafness and Hereditary Hearing Loss Overview</related-object>) in the absence of the characteristic ocular features.</p>
      </sec>
      <sec id="norrie.Management">
        <title>Management</title>
        <sec id="norrie.Evaluations_Following_Initial_Dia">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with <italic toggle="yes">NDP</italic>-related retinopathies, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Complete ophthalmologic examination</p>
            </list-item>
            <list-item>
              <p>Baseline audiologic evaluation</p>
            </list-item>
            <list-item>
              <p>Neurodevelopmental assessment in early childhood if developmental milestones are not met</p>
            </list-item>
            <list-item>
              <p>Behavioral evaluation as needed</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="norrie.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>
            <bold>Ocular manifestations</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The majority of males with the classic Norrie disease (ND) phenotype have complete retinal detachment at the time of birth; therefore, interventional therapy may not offer much with regard to preservation of sight. Ophthalmologic evaluation is warranted..</p>
            </list-item>
            <list-item>
              <p>Individuals without complete retinal detachment may benefit from surgery and/or laser therapy with the potential for improved outcomes if done at an early age.</p>
              <list list-type="bullet">
                <list-item>
                  <p>A report by <xref ref-type="bibr" rid="norrie.REF.chow.2010.2402">Chow et al [2010]</xref> described successful laser photocoagulation at birth (37 weeks&#x02019; gestation) of a male with ND in which Teller visual acuity was measured at 20/100 O.D. at 23 months of life</p>
                </list-item>
                <list-item>
                  <p>Retrospective medical record review of all patients seen in a tertiary care pediatric retinal clinical practice (1988-2008) of 14 males with ND documented maintenance of light perception in at least one eye (7/14 cases) with early vitrectomy done by age 12 months (median 4.5 months) [<xref ref-type="bibr" rid="norrie.REF.walsh.2010.456">Walsh et al 2010</xref>].</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>In the progressive stage of the Norrie disease phenotype, development of increased intraocular pressure may require surgery. Rarely, enucleation of the eye is required to control pain.</p>
            </list-item>
          </list>
          <p>
            <bold>Sensorineural hearing loss</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Hearing aid augmentation is usually successful well into middle or late adulthood.</p>
            </list-item>
            <list-item>
              <p>Cochlear implantation should be considered when hearing-assisted audiologic function is significantly impaired.</p>
            </list-item>
          </list>
          <p><bold>Behavioral issues</bold> are a lifelong challenge to many individuals with Norrie disease and to their guardians/caretakers, whether or not intellectual disability or cognitive impairment is present. Intervention and therapy are supportive and aimed at maximizing educational opportunities.</p>
          <p>An empiric trial of psychotropic medications may be warranted, although no studies have addressed or supported the use of specific medications for treatment of Norrie disease.</p>
        </sec>
        <sec id="norrie.Surveillance">
          <title>Surveillance</title>
          <p>The following are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Routine follow up with an ophthalmologist in all individuals with an <italic toggle="yes">NDP</italic>-related retinopathy, even when vision is severely reduced</p>
            </list-item>
            <list-item>
              <p>Given that most individuals with the <italic toggle="yes">NDP</italic>-related spectrum of retinopathies are blind, routine monitoring of hearing so that hearing loss can be detected early and managed appropriately</p>
            </list-item>
            <list-item>
              <p>Observation for clinical evidence of venous stasis or ulcer disease</p>
            </list-item>
          </list>
        </sec>
        <sec id="norrie.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Given the increased risk of hearing loss, exposure to loud noises should be avoided.</p>
        </sec>
        <sec id="norrie.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="norrie.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes</p>
        </sec>
        <sec id="norrie.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>A planned delivery at 34 weeks&#x02019; gestation of a male with an established <italic toggle="yes">NDP</italic> pathogenic variant (in whom retinal detachment was excluded following fetal ultrasonography at 28 and 33 weeks) was reported [<xref ref-type="bibr" rid="norrie.REF.sisk.2014.1312">Sisk et al 2014</xref>]. Authors describe treatment at two days of life with laser ablation of the avascular retina in both eyes and ten-month follow up which showed the retina to remain completely attached in both eyes [<xref ref-type="bibr" rid="norrie.REF.sisk.2014.1312">Sisk et al 2014</xref>].</p>
        </sec>
        <sec id="norrie.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p><xref ref-type="bibr" rid="norrie.REF.ohlmann.2005.1701">Ohlmann et al [2005]</xref> have elaborated in the mouse knockout a failure of retinal angiogenesis and documented correction of the ocular-vascular phenotype by transgenic ectopic lens expression of norrin. These authors also noted a potential effect of norrin on retinal ganglion cell proliferation.</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="norrie.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="norrie.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">NDP</italic>-related retinopathies are inherited in an X-linked manner.</p>
        </sec>
        <sec id="norrie.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a male proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The father of a male proband is neither affected nor is he a carrier.</p>
            </list-item>
            <list-item>
              <p>The majority of mothers of a male proband are carriers of an <italic toggle="yes">NDP</italic> pathogenic variant, even when the family history is negative.</p>
            </list-item>
            <list-item>
              <p>Rarely, affected males have a <italic toggle="yes">de novo</italic> pathogenic variant. Women who are carriers may have an inherited or <italic toggle="yes">de novo</italic> pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>Women who have an affected child and one other affected relative are obligate heterozygotes (carriers).</p>
            </list-item>
          </list>
          <p><bold>Sibs of a male proband.</bold> The risk to sibs depends on the carrier status of the mother:</p>
          <list list-type="bullet">
            <list-item>
              <p>If the mother of the proband has an <italic toggle="yes">NDP</italic> pathogenic variant, the chance of transmitting it in each pregnancy is 50%. Male sibs who inherit the pathogenic variant will be affected; female sibs who inherit the pathogenic variant will be carriers and will generally not be affected.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant has not been identified in DNA extracted from the mother's leukocytes, the risk to sibs is low but greater than that of the general population because of the possibility of germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a male proband.</bold> Males with an <italic toggle="yes">NDP</italic>-related retinopathy will pass the <italic toggle="yes">NDP</italic> pathogenic variant to all of their daughters, who will be carriers, and to none of their sons.</p>
          <p><bold>Other family members of a male proband.</bold> The proband's maternal aunts may be at risk of being carriers of an <italic toggle="yes">NDP</italic> pathogenic variant and the aunts&#x02019; offspring, depending on their gender, may be at risk of being carriers or of being affected.</p>
        </sec>
        <sec id="norrie.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Identification of female carriers requires:</p>
          <list list-type="bullet">
            <list-item>
              <p>Prior identification of the <italic toggle="yes">NDP</italic> pathogenic variant in the family; OR</p>
            </list-item>
            <list-item>
              <p>If an affected male is not available for testing, molecular genetic testing first by sequence analysis, and if no <italic toggle="yes">NDP</italic> pathogenic variant is identified, then by deletion/duplication analysis (see <xref ref-type="table" rid="norrie.T.summary_of_molecular_genetic_te">Table 2</xref>).OR</p>
            </list-item>
            <list-item>
              <p>Linkage analysis if:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Sequence analysis and deletion analysis do not identify a pathogenic variant;AND</p>
                </list-item>
                <list-item>
                  <p>The family structure is appropriate for linkage studies;AND</p>
                </list-item>
                <list-item>
                  <p>The necessary family members are available for testing.</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>Note: Carriers are heterozygotes for this X-linked disorder and rarely develop clinical findings related to the disorder; however, individuals with manifestations have been described [<xref ref-type="bibr" rid="norrie.REF.lin.2010.93">Lin et al 2010</xref>, <xref ref-type="bibr" rid="norrie.REF.romaniello.2013.1702">Romaniello et al 2013</xref>, <xref ref-type="bibr" rid="norrie.REF.parzefall.2014.203">Parzefall et al 2014</xref>] and caution should be maintained when discussing carrier risk in the context of genetic and prenatal counseling.</p>
        </sec>
        <sec id="norrie.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="norrie.Prenatal_Testing_and_Preimplantat">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">NDP</italic> pathogenic variant has been identified in an affected family member, prenatal testing and preimplantation genetic diagnosis for a pregnancy at increased risk for an <italic toggle="yes">NDP</italic>-related retinopathy are possible options.</p>
        </sec>
      </sec>
      <sec id="norrie.Resources">
        <title>Resources</title>
      </sec>
      <sec id="norrie.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="norrie.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>Mouse model studies have documented that norrin deficiency plays a critical role in the retinal and cochlear vasculopathy [<xref ref-type="bibr" rid="norrie.REF.xu.2004.883">Xu et al 2004</xref>, <xref ref-type="bibr" rid="norrie.REF.hendrickx.2008.229">Hendrickx &#x00026; Leyns 2008</xref>] and presumably the same pathobiologic failure of normal angiogenesis underlies the visual failure and risk of hearing loss and/or intellectual disability in human ND. Studies in the knockout mouse (<italic toggle="yes">Ndp y/-</italic>) have shown failure of retinal angiogenesis with complete lack of the deep capillary layers of the retina and progressive loss of vessels in the stria vascularis of the cochlea [<xref ref-type="bibr" rid="norrie.REF.rehm.2002.4286">Rehm et al 2002</xref>]. This failed retinal vascularization presumably leads to retinal hypoxia and fatal retinal injury [<xref ref-type="bibr" rid="norrie.REF.luhmann.2005.3372">Luhmann et al 2005</xref>].</p>
          <p>Norrin binds to the Fzd4 CRD [<xref ref-type="bibr" rid="norrie.REF.smallwood.2007.4057">Smallwood et al 2007</xref>]. Norrin-Fzd4 signaling [<xref ref-type="bibr" rid="norrie.REF.ye.2010.417">Ye et al 2010</xref>], with subsequent activation of the classic Wnt pathway, plays a central role in retinal vascular development [<xref ref-type="bibr" rid="norrie.REF.xu.2004.883">Xu et al 2004</xref>, <xref ref-type="bibr" rid="norrie.REF.warden.2007.211">Warden et al 2007</xref>, <xref ref-type="bibr" rid="norrie.REF.parmalee.2008.558">Parmalee &#x00026; Kitajewski 2008</xref>, <xref ref-type="bibr" rid="norrie.REF.ohlmann.2012.243">Ohlmann &#x00026; Tamm 2012</xref>] including effect on endothelial cell proliferation, migration and retinal invasion, arterial and venous topography, and stability of the BBB and BRB through regulation of transcription factors, cell surface receptors, and cell junction proteins [<xref ref-type="bibr" rid="norrie.REF.paes.2011.6452">Paes et al 2011</xref>, <xref ref-type="bibr" rid="norrie.REF.wang.2012.1332">Wang et al 2012</xref>]. Norrin also has significant neuroprotective properties through activation of Wnt/beta-catenin signaling [<xref ref-type="bibr" rid="norrie.REF.seitz.2010.5998">Seitz et al 2010</xref>] and induction of neuroprotective growth factor synthesis in Muller cells [<xref ref-type="bibr" rid="norrie.REF.ohlmann.2012.243">Ohlmann &#x00026; Tamm 2012</xref>]. Norrin is expressed widely in brain astrocytes and cerebellar Bergmann glia [<xref ref-type="bibr" rid="norrie.REF.ye.2011.151">Ye et al 2011</xref>], suggesting an as-yet unclarified phenotypic role in these CNS systems.</p>
          <p>The role that norrin plays in intellectual disability remains unclear. Recently, <italic toggle="yes">NDP</italic> expression was shown to be initiated in retinal progenitors in response to Hedgehog (Hh) signaling through induction of Gli2 binding to the <italic toggle="yes">NDP</italic> promoter [<xref ref-type="bibr" rid="norrie.REF.mcneill.2013.1005">McNeill et al 2013</xref>]. The authors hypothesized a possible role for <italic toggle="yes">Ndp</italic> in more global neural function, given the identification of <italic toggle="yes">Ndp</italic> function in neural progenitor proliferation apart from its function in the retinal vasculature.</p>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">NDP</italic> spans 28 kb of genomic DNA. The cDNA comprises three exons, and the coding portion spans the latter half of exon 2 and the first portion of exon 3 yielding a mRNA of 2.1 kb. Exon 1 is untranslated and may function as a promoter region for gene transcription. ND-associated pathogenic variants have been identified in exon 1 [<xref ref-type="bibr" rid="norrie.REF.schuback.1995.285">Schuback et al 1995</xref>, <xref ref-type="bibr" rid="norrie.REF.kenyon.1999.181">Kenyon &#x00026; Craig 1999</xref>], although their functional significance remains controversial. A cysteine-rich region, presumed critical to secondary protein structure, exists in the carboxyl terminus of exon 3. It is here that the majority of pathogenic variants have been identified, although such variants are widely dispersed throughout the coding region. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="norrie" object-id="norrie.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Benign allelic variants.</bold> The possibility remains that single-nucleotide variants (SNVs) may play a role in ND clinical phenotypic expression or modulation. Both insertion and deletion variants in exon 1, associated with advanced ROP, have been described [<xref ref-type="bibr" rid="norrie.REF.hiraoka.2001a.178">Hiraoka et al 2001a</xref>, <xref ref-type="bibr" rid="norrie.REF.dickinson.2006.682">Dickinson et al 2006</xref>, <xref ref-type="bibr" rid="norrie.REF.wu.2007.225">Wu et al 2007</xref>]. Exon 1 insertions and deletions have been seen in a number of controls [Sims, unpublished data], suggesting that these may be benign. It remains, however, a possibility that these exon 1 variants predispose to a clinical vascular phenotype in certain at-risk cohorts.</p>
          <p><bold>Pathogenic allelic variants.</bold> More than 100 <italic toggle="yes">NDP</italic> pathogenic variants (missense, null, splice, deletions) have been described [<xref ref-type="bibr" rid="norrie.REF.ye.2010.417">Ye et al 2010</xref>]. The majority of pathogenic variants are single base-pair changes identified in the coding region of <italic toggle="yes">NDP</italic> [<xref ref-type="bibr" rid="norrie.REF.schuback.1995.285">Schuback et al 1995</xref>, <xref ref-type="bibr" rid="norrie.REF.shastry.1998.35">Shastry 1998</xref>, <xref ref-type="bibr" rid="norrie.REF.zaremba.1998.157">Zaremba et al 1998</xref>, <xref ref-type="bibr" rid="norrie.REF.black.1999.2031">Black et al 1999</xref>, <xref ref-type="bibr" rid="norrie.REF.hiraoka.2001b.53">Hiraoka et al 2001b</xref>, <xref ref-type="bibr" rid="norrie.REF.yamada.2001.52">Yamada et al 2001</xref>, <xref ref-type="bibr" rid="norrie.REF.dickinson.2006.682">Dickinson et al 2006</xref>, <xref ref-type="bibr" rid="norrie.REF.drenser.2007.243">Drenser et al 2007</xref>, <xref ref-type="bibr" rid="norrie.REF.kondo.2007.1276">Kondo et al 2007</xref>, <xref ref-type="bibr" rid="norrie.REF.lev.2007.921">Lev et al 2007</xref>, <xref ref-type="bibr" rid="norrie.REF.wu.2007.225">Wu et al 2007</xref>, <xref ref-type="bibr" rid="norrie.REF.khan.2008.730">Khan et al 2008</xref>, <xref ref-type="bibr" rid="norrie.REF.yang.2012.726">Yang et al 2012</xref>].</p>
          <p>More than 20 DNA rearrangements have been noted including intragenic (small) deletions, or submicroscopic <italic toggle="yes">("NDP</italic> plus") deletions and account for approximately 15% of pathogenic variants [<xref ref-type="bibr" rid="norrie.REF.berger.2001">Berger &#x00026; Ropers 2001</xref>; <xref ref-type="bibr" rid="norrie.REF.rodriguezrevenga.2007.916">Rodriguez-Revenga et al 2007</xref>; <xref ref-type="bibr" rid="norrie.REF.staropoli.2010.786">Staropoli et al 2010</xref>; Sims, unpublished data]. Affected individuals with insertions [<xref ref-type="bibr" rid="norrie.REF.hiraoka.2001a.178">Hiraoka et al 2001a</xref>], complex rearrangements [<xref ref-type="bibr" rid="norrie.REF.schuback.1995.285">Schuback et al 1995</xref>], and X;autosome translocations [<xref ref-type="bibr" rid="norrie.REF.meire.1998.203">Meire et al 1998</xref>] have been documented. A few of these individuals have deletions that have been identified as extending beyond the <italic toggle="yes">NDP</italic> locus. These individuals have more complex phenotypes suggestive of contiguous gene syndromes [<xref ref-type="bibr" rid="norrie.REF.sims.1989.1069">Sims et al 1989</xref>, <xref ref-type="bibr" rid="norrie.REF.su_rezmerino.2001.523">Su&#x000e1;rez-Merino et al 2001</xref>, <xref ref-type="bibr" rid="norrie.REF.rodriguezrevenga.2007.916">Rodriguez-Revenga et al 2007</xref>, <xref ref-type="bibr" rid="norrie.REF.staropoli.2010.786">Staropoli et al 2010</xref>].</p>
          <p><xref ref-type="bibr" rid="norrie.REF.ke.2013.2305">Ke et al [2013]</xref> characterized five categories of pathogenic variant based on crystalline structure of <italic toggle="yes">NDP</italic>: (1) cysteine residue, (2) dimer interface, (3) hydrophobic core, (4) <italic toggle="yes">Fzd4</italic> binding site, and (5) <italic toggle="yes">Lrp5/6</italic> binding site variants. Fzd4 cysteine-rich domain (CRD) variants had previously been shown to affect Norrin binding and signaling [<xref ref-type="bibr" rid="norrie.REF.zhang.2011.10210">Zhang et al 2011</xref>].</p>
          <p>Most pathogenic variants are unique and have been identified in single individuals/families; a few pathogenic variants have been seen in multiple, apparently unrelated families. Founder variants have not been identified. The pathogenic missense variants all predict significant amino acid change and often affect one of the many cysteine residues immediately adjacent to a cysteine. These cysteine residues are presumed important for the maintenance of protein structure, and pathogenic variants in these residues would be potentially deleterious to protein function.</p>
          <p><bold>Normal gene product.</bold> Norrin [<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000266">NM_000266</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000257">NP_000257</ext-link>] is a secreted protein comprising 133 amino acids; it has a cysteine-knot motif (highly conserved in many growth factors). Crystal structure analysis indicates that norrin exists as a homodimer and that dimer formation is required for binding to Frizzled-4 (Fzd4) receptors [<xref ref-type="bibr" rid="norrie.REF.ke.2013.2305">Ke et al 2013</xref>]. This binding activates the canonical Wnt/beta-catenin signaling pathway and is enhanced by Tspan12 [<xref ref-type="bibr" rid="norrie.REF.junge.2009.299">Junge et al 2009</xref>]. Norrin is critical in CNS vascular development as norrin is required for angiogenesis in the eye, ear, and brain; maintains the blood-brain-barrier (BBB) and the blood-retinal-barrier (BRB); and exhibits neuro-protective properties for retinal neurons.</p>
          <p>Messenger RNA localization by in situ hybridization to the outer nuclear layer, inner nuclear layer and ganglion cell layer of the retina (mice, rabbit, human) early on suggested a role in retinal development [<xref ref-type="bibr" rid="norrie.REF.hartzer.1999.355">Hartzer et al 1999</xref>]. Later and ongoing animal model studies (see <bold>Abnormal gene product</bold>) have continued to support a role for norrin in cellular or tissue differentiation and maintenance of cellular phenotype and in intercellular communication, critical to normal retinal, CNS, and cochlear development.</p>
          <p><bold>Abnormal gene product.</bold> The phenotype of the norrin-deficient mouse models (<italic toggle="yes">Ndp y/-</italic>) shows impaired retinal vascular development with inadequate capillary outgrowth into the retinal surface and attendant loss of all intraretinal capillaries [<xref ref-type="bibr" rid="norrie.REF.richter.1998.2450">Richter et al 1998</xref>, <xref ref-type="bibr" rid="norrie.REF.rehm.2002.4286">Rehm et al 2002</xref>, <xref ref-type="bibr" rid="norrie.REF.luhmann.2005.3372">Luhmann et al 2005</xref>, <xref ref-type="bibr" rid="norrie.REF.ohlmann.2005.1701">Ohlmann et al 2005</xref>] as well abnormal persistence of the hyaloid vasculature. Late-onset hearing loss was seen associated with cochlear degeneration [<xref ref-type="bibr" rid="norrie.REF.berger.1998.95">Berger 1998</xref>] and abnormal vessels in the inner ear were described [<xref ref-type="bibr" rid="norrie.REF.rehm.2002.4286">Rehm et al 2002</xref>, <xref ref-type="bibr" rid="norrie.REF.ohlmann.2005.1701">Ohlmann et al 2005</xref>]. Differential gene expression in <italic toggle="yes">Ndp</italic> knockout mice provides further evidence of a role for norrin in retinal vascular development [<xref ref-type="bibr" rid="norrie.REF.sch_fer.2009.906">Sch&#x000e4;fer et al 2009</xref>, <xref ref-type="bibr" rid="norrie.REF.ye.2011.151">Ye et al 2011</xref>, <xref ref-type="bibr" rid="norrie.REF.lee.2013.447">Lee et al 2013</xref>].</p>
          <p>Exogenous norrin has been shown to restore the normal retinal vascular network [<xref ref-type="bibr" rid="norrie.REF.ohlmann.2005.1701">Ohlmann et al 2005</xref>], suppress vascular loss and pathologic neovascularization in a mouse model of ROP [<xref ref-type="bibr" rid="norrie.REF.ohlmann.2010.183">Ohlmann et al 2010</xref>], and rescue the retinal vasculature in a mouse model of oxygen-induced retinopathy [<xref ref-type="bibr" rid="norrie.REF.tokunaga.2013.222">Tokunaga et al 2013</xref>]. Overexpression of norrin activates the Wnt/beta-catenin and endothelin-2 signaling and protects photoreceptors from light damage [<xref ref-type="bibr" rid="norrie.REF.braunger.2013.1">Braunger et al 2013</xref>].</p>
        </sec>
      </sec>
      <sec id="norrie.References">
        <title>References</title>
        <sec id="norrie.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="norrie.Literature_Cited.reflist0">
            <ref id="norrie.REF.allen.2006.234">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Allen</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russell</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Streb</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alsheikheh</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stone</surname>
                    <given-names>EM</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Phenotypic heterogeneity associated with a novel mutation (Gly112Glu) in the Norrie disease protein.</article-title>
                <source>Eye</source>
                <volume>20</volume>
                <fpage>234</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">15776010</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.anderson.2012.338">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kasher</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szynkiewicz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jenkinson</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhaskar</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urquhart</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daly</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dickerson</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Sullivan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leibundgut</surname>
                    <given-names>EO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muter</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abdel-Salem</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Babul-Hirji</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baxter</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berger</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonaf&#x000e9;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunstom-Hernandez</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buckard</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chitayat</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chong</surname>
                    <given-names>WK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cordelli</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferreira</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fluss</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forrest</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franzoni</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garone</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hammans</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houge</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacquemont</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeannet</surname>
                    <given-names>PY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jefferson</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumar</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kutschke</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lundberg</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Louren&#x000e7;o</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mehta</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naidu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nischal</surname>
                    <given-names>KK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nunes</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ounap</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philippart</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prabhakar</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Risen</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soh</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stephenson</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stewart</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stone</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolmie</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vieira</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilain</surname>
                    <given-names>CN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wakeling</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wermenbol</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whitney</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lovell</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Livingston</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baerlocher</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Black</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rice</surname>
                    <given-names>GI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crow</surname>
                    <given-names>YJ</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus.</article-title>
                <source>Nat Genet.</source>
                <year>2012</year>
                <volume>44</volume>
                <fpage>338</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">22267198</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.arai.2014.448">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Arai</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujimaki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yanagawa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujiki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yokoyama</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okumura</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murakami</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Familial cases of Norrie disease detected by copy number analysis.</article-title>
                <source>Jpn J Ophthalmol.</source>
                <volume>58</volume>
                <fpage>448</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">25023092</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.berger.1998.95">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Berger</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Molecular dissection of Norrie disease.</article-title>
                <source>Acta Anat (Basel)</source>
                <volume>162</volume>
                <fpage>95</fpage>
                <lpage>100</lpage>
                <pub-id pub-id-type="pmid">9831755</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.berger.2001">
              <mixed-citation publication-type="book">Berger W, Ropers H-H. Norrie disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Vogelstein B, eds. <italic toggle="yes">The Metabolic and Molecular Bases of Inherited Disease.</italic> 8 ed. New York, NY: McGraw-Hill; 2001:5977-85.</mixed-citation>
            </ref>
            <ref id="norrie.REF.black.1999.2031">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Black</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perveen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonshek</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cahill</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clayton-Smith</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lloyd</surname>
                    <given-names>IC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLeod</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Coats' disease of the retina (unilateral retinal telangiectasis) caused by somatic mutation in the NDP gene: a role for norrin in retinal angiogenesis.</article-title>
                <source>Hum Mol Genet</source>
                <volume>8</volume>
                <fpage>2031</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">10484772</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.braunger.2013.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Braunger</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohlmann</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koch</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanimoto</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Volz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bosl</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cvekl</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jagle</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seeliger</surname>
                    <given-names>MW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamm</surname>
                    <given-names>ER</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Constitutive overexpression of Norrin activates Wnt/beta-catenin and endothelin-2 signaling to protect photoreceptors from light damage.</article-title>
                <source>Neurobiol Dis.</source>
                <volume>50</volume>
                <fpage>1</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">23009755</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.chow.2010.2402">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chow</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kiernan</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chau</surname>
                    <given-names>FY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blair</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ticho</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galasso</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sahpiro</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Laser photocoagulation at birth prevents blindness in Norrie&#x02019;s disease diagnosed using amniocentesis.</article-title>
                <source>Ophthalmology</source>
                <volume>117</volume>
                <fpage>2402</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">20619898</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.dickinson.2006.682">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dickinson</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sale</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Passmore</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fitzgerald</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wheatley</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burdon</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Craig</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tengtrisorn</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carden</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maclean</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackey</surname>
                    <given-names>DA</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Mutations in the NDP gene: contribution to Norrie disease, familial exudative vitreoretinopathy and retinopathy of prematurity.</article-title>
                <source>Clinical and Experimental Ophthalmology</source>
                <volume>34</volume>
                <fpage>682</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16970763</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.drenser.2007.243">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Drenser</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fecko</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dailey</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trese</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <article-title>A characteristic phenotypic retinal appearance in Norrie disease.</article-title>
                <source>Retina.</source>
                <year>2007</year>
                <volume>27</volume>
                <fpage>243</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17290208</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.haider.2002.365">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Haider</surname>
                    <given-names>MZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devarajan</surname>
                    <given-names>LV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Essa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumar</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>A C597--&#x0003e;A polymorphism in the Norrie disease gene is associated with advanced retinopathy of prematurity in premature Kuwaiti infants.</article-title>
                <source>J Biomed Sci</source>
                <volume>9</volume>
                <fpage>365</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">12145535</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.haider.2001.120">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Haider</surname>
                    <given-names>MZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devarajan</surname>
                    <given-names>LV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Essa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Srivastva</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumar</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azad</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rashwan</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Retinopathy of prematurity: mutations in the Norrie disease gene and the risk of progression to advanced stages.</article-title>
                <source>Pediatr Int</source>
                <volume>43</volume>
                <fpage>120</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">11285060</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.halpin.2005.533">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Halpin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Owen</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gutierrez-Espeleta</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sims</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rehm</surname>
                    <given-names>HL</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Audiologic features of Norrie disease.</article-title>
                <source>Ann Otol Rhinol Laryngol</source>
                <volume>114</volume>
                <fpage>533</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16134349</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.halpin.2008.1705">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Halpin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sims</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Twenty years of audiology in a patient with Norrie disease.</article-title>
                <source>Int J Pediatr Otorhinolaryngol.</source>
                <volume>72</volume>
                <fpage>1705</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">18817988</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.hartzer.1999.355">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hartzer</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheng</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shastry</surname>
                    <given-names>BS</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Localization of the Norrie disease gene mRNA by in situ hybridization.</article-title>
                <source>Brain Res Bull</source>
                <volume>49</volume>
                <fpage>355</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10452356</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.hendrickx.2008.229">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hendrickx</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leyns</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Non-conventional Frizzled ligands and Wnt receptors.</article-title>
                <source>Dev Growth Differ</source>
                <volume>50</volume>
                <fpage>229</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">18366384</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.hiraoka.2001a.178">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hiraoka</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berinstein</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trese</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shastry</surname>
                    <given-names>BS</given-names>
                  </name>
                </person-group>
                <year>2001a</year>
                <article-title>Insertion and deletion mutations in the dinucleotide repeat region of the Norrie disease gene in patients with advanced retinopathy of prematurity.</article-title>
                <source>J Hum Genet</source>
                <volume>46</volume>
                <fpage>178</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">11322656</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.hiraoka.2001b.53">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hiraoka</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trese</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shastry</surname>
                    <given-names>BS</given-names>
                  </name>
                </person-group>
                <year>2001b</year>
                <article-title>X-linked juvenile retinoschisis: mutations at the retinoschisis and Norrie disease gene loci?</article-title>
                <source>J Hum Genet</source>
                <volume>46</volume>
                <fpage>53</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">11281412</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.hiraoka.2010.2572">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hiraoka</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orimo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hiraoka</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogata</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azuma</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Genetic screening of Wnt signaling factors in advanced retinopathy of prematurity.</article-title>
                <source>Mol Vis.</source>
                <volume>16</volume>
                <fpage>2572</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">21151595</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.hutcheson.2005.501">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hutcheson</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paluru</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernstein</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koh</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rappaport</surname>
                    <given-names>EF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leach</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>TL</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Norrie disease gene sequence variants in an ethnically diverse population with retinopathy of prematurity.</article-title>
                <source>Mol Vis</source>
                <volume>11</volume>
                <fpage>501</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16052165</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.jiao.2004.878">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jiao</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ventruto</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trese</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shastry</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hejtmancik</surname>
                    <given-names>JF</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Autosomal recessive familial exudative vitroretionopathy is aoiated with mutations in LRP5.</article-title>
                <source>Am J Hum Genet.</source>
                <volume>75</volume>
                <fpage>878</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">15346351</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.junge.2009.299">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Junge</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yng</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burton</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paes</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sh</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>French</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Costa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rice</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ye</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>TSPAN12 regulates retinal vascular development by promoting Norrin- but not Wnt-induced FZD4/beta-catenin signaling.</article-title>
                <source>Cell</source>
                <volume>139</volume>
                <fpage>299</fpage>
                <lpage>311</lpage>
                <pub-id pub-id-type="pmid">19837033</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.ke.2013.2305">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ke</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harikumar</surname>
                    <given-names>KG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erice</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parker</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheng</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>BO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melcher</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>HE</given-names>
                  </name>
                </person-group>
                <article-title>Structure and function of Norrin in assembly and activation of a Frizzled 4-Lrp5/6 complex.</article-title>
                <source>Genes Dev.</source>
                <year>2013</year>
                <volume>27</volume>
                <fpage>2305</fpage>
                <lpage>19</lpage>
                <pub-id pub-id-type="pmid">24186977</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.kenyon.1999.181">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kenyon</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Craig</surname>
                    <given-names>IW</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Analysis of the 5' regulatory region of the human Norrie's disease gene: evidence that a non-translated CT dinucleotide repeat in exon one has a role in controlling expression.</article-title>
                <source>Gene</source>
                <volume>227</volume>
                <fpage>181</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10023053</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.khan.2008.730">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>AO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aldahmesh</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyer</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Correlation of ophthalmic examination in carrier status in females potentially harboring a severe Norrie disease gene mutations.</article-title>
                <source>Ophthalmology</source>
                <volume>115</volume>
                <fpage>730</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">18387409</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.khan.2004.361">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>AO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shamsi</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Saif</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kambouris</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>A novel missense Norrie disease mutation associated with a severe ocular phenotype.</article-title>
                <source>J Pediatr Ophthalmol Strabismus</source>
                <volume>41</volume>
                <fpage>361</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">15609522</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.kondo.2007.1276">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kondo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kusaka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tahira</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hasebe</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uchio</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Novel mutations in Norrie disease gene in Japanese patients with Norrie disease and familial exudative vitreoretinopathy.</article-title>
                <source>Invest. Ophthalmol. Vis. Sci.</source>
                <volume>48</volume>
                <fpage>1276</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">17325173</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.lee.2013.447">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jo</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>JH</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Norrin expression in endothelial cells in the developing mouse retina.</article-title>
                <source>Acta Histochem.</source>
                <volume>115</volume>
                <fpage>447</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">23206555</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.lenzner.2002.2825">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lenzner</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prietz</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feil</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nuber</surname>
                    <given-names>UA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ropers</surname>
                    <given-names>H-H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berger</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Global gene expression analysis in a mouse model for Norrie disease: late involvement of photoreceptor cells.</article-title>
                <source>Invest. Ophthalmol. Vis. Sci.</source>
                <volume>43</volume>
                <fpage>2825</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">12202498</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.lev.2007.921">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lev</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weigl</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hasan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gak</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davidovich</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vinkler</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leshinsky-Silver</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerman-Sagie</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watemberg</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>A novel missense mutation in the NDP gene in a child with Norrie disease and severe neurological involvement including infantile spasms.</article-title>
                <source>Am J Med Genet A</source>
                <volume>143A</volume>
                <fpage>921</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">17334993</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.lin.2010.93">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shankar</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duncan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slavotinek</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stone</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rutar</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Retinal vascular abnormalities and dragged maculae in a carrier with a new NDP mutation (c.268delC) that caused severe Norrie disease in the proband.</article-title>
                <source>J AAPOS</source>
                <volume>14</volume>
                <fpage>93</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">20227630</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.liu.2010.2653">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hu</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peng</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mo</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Su</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pan</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xia</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>A novel nonsense mutation in the <italic toggle="yes">NDP</italic> gene in a Chinese family with Norrie disease.</article-title>
                <source>Mol Vis</source>
                <volume>16</volume>
                <fpage>2653</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">21179243</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.luhmann.2005.3372">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Luhmann</surname>
                    <given-names>UF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Acar</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lammel</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feil</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grimm</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seeliger</surname>
                    <given-names>MW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hammes</surname>
                    <given-names>HP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berger</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Role of the Norrie disease pseudoglioma gene in sprouting angiogenesis during development of the retinal vasculature.</article-title>
                <source>Invest Ophthalmol Vis Sci</source>
                <volume>46</volume>
                <fpage>3372</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">16123442</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.luhmann.2008.2619">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Luhmann</surname>
                    <given-names>UFO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neidhardt</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kloeckener-Gruissem</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sch&#x000e4;fer</surname>
                    <given-names>NF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glaus</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feil</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berger</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Vascular changes in the cerebellum of Norrin/Ndph knockout mice correlate with high expression of Norrin and Frizzled-4.</article-title>
                <source>Eur. J Neurosci.</source>
                <volume>27</volume>
                <fpage>2619</fpage>
                <lpage>28</lpage>
                <pub-id pub-id-type="pmid">18547247</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.mcneill.2013.1005">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McNeill</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazerolle</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bassett</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mears</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ringuette</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lagali</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Picketts</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paes</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rice</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallace</surname>
                    <given-names>VA</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Nedgehog regulates Norrie disease protein to drive neural progenitor self-renewal.</article-title>
                <source>Hum Mol Genet.</source>
                <volume>22</volume>
                <fpage>1005</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">23201751</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.meire.1998.203">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Meire</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lafaut</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Speleman</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanssens</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Isolated Norrie disease in a female caused by a balanced translocation t(X,6).</article-title>
                <source>Ophthalmic Genet</source>
                <volume>19</volume>
                <fpage>203</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9895245</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.nikopoulos.2010a.240">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nikopoulos</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilissen</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoischen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Nouhuys</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boonstra</surname>
                    <given-names>FN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blokland</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arts</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wieskamp</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strom</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ayuso</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tilanus</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouwhuis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mukhopadhyay</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoefsloot</surname>
                    <given-names>LH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veltman</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cremers</surname>
                    <given-names>FP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collin</surname>
                    <given-names>RW</given-names>
                  </name>
                </person-group>
                <article-title>Next-generation sequencing of a 40 Mb linkage interval reveals TSPAN12 mutations in patients with familial exudative vitreoretinopathy.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2010a</year>
                <volume>86</volume>
                <fpage>240</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">20159111</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.nikopoulos.2010b.656">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nikopoulos</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venselaar</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collin</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riveiro-Alvarez</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boonstra</surname>
                    <given-names>FN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hooymans</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mukhopadhyay</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shears</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Bers</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Wijs</surname>
                    <given-names>IJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Essen</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sijmons</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tilanus</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Nouhuys</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ayuso</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoefsloot</surname>
                    <given-names>LH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cremers</surname>
                    <given-names>FP</given-names>
                  </name>
                </person-group>
                <article-title>Overview of the mutation spectrum in familial exudative vitreoretinopathy and Norrie disease with identification of 21 novel variants in FZD4, LRP5, and NDP.</article-title>
                <source>Hum Mutat.</source>
                <year>2010b</year>
                <volume>31</volume>
                <fpage>656</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">20340138</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.ohlmann.2005.1701">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ohlmann</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scholz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldwich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chauhan</surname>
                    <given-names>BK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hudl</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohlmann</surname>
                    <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zrenner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berger</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cvekl</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seeliger</surname>
                    <given-names>MW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamm</surname>
                    <given-names>ER</given-names>
                  </name>
                </person-group>
                <article-title>Ectopic norrin induces growth of ocular capillaries and restores normal retinal angiogenesis in Norrie disease mutant mice.</article-title>
                <source>J Neurosci.</source>
                <year>2005</year>
                <volume>25</volume>
                <fpage>1701</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">15716406</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.ohlmann.2010.183">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ohlmann</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seitz</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Braunger</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seitz</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000f6;sl</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamm</surname>
                    <given-names>ER</given-names>
                  </name>
                </person-group>
                <article-title>Norrin promotes vascular regrowth after oxygen-induced retinal vessel loss and suppresses retinopathy in mice.</article-title>
                <source>J Neurosci.</source>
                <year>2010</year>
                <volume>30</volume>
                <fpage>183</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">20053900</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.ohlmann.2012.243">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ohlmann</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamm</surname>
                    <given-names>ER</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Norrin: molecular and functional properties of an angiogenic and neuroprotective growth factor.</article-title>
                <source>Prog Retin Eye Res.</source>
                <volume>31</volume>
                <fpage>243</fpage>
                <lpage>57</lpage>
                <pub-id pub-id-type="pmid">22387751</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.paes.2011.6452">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Paes</surname>
                    <given-names>KT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henze</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogel</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Read</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suwanichkul</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirkpatrick</surname>
                    <given-names>LL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Potter</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newhouse</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rice</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <article-title>Frizzled 4 is required for retinal angiogenesis and maintenance of the blood-retina barrier.</article-title>
                <source>Invest Ophthalmol Vis Sci.</source>
                <year>2011</year>
                <volume>52</volume>
                <fpage>6452</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">21743011</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.parmalee.2008.558">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Parmalee</surname>
                    <given-names>NL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kitajewski</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Wnt signaling in angiogenesis.</article-title>
                <source>Current Drug Targets</source>
                <volume>9</volume>
                <fpage>558</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">18673241</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.parzefall.2014.203">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Parzefall</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucas</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ritter</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ludwig</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramsebner</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frohne</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schofer</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hengstschlager</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frei</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>A novel missense NDP mutation [p.(Cys93Arg)] with a manifesting carrier in an Austrian family with Norrie disease.</article-title>
                <source>Audiol Neurootol.</source>
                <volume>19</volume>
                <fpage>203</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">24801666</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.polvi.2012.540">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Polvi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linnankivi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kivel&#x000e4;</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herva</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keating</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000e4;kitie</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pareyson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vainionp&#x000e4;&#x000e4;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lahtinen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hovatta</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pihko</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehesjoki</surname>
                    <given-names>AE</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in CTC1, encoding the CTS telomere maintenance complex component 1, cause cerebroretinal microangiopathy with calcifications and cysts.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2012</year>
                <volume>90</volume>
                <fpage>540</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">22387016</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.poulter.2010.248">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Poulter</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ali</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilmour</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kondo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackey</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kearns</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruddle</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Craig</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pierce</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Downey</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohamed</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markham</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inglehearn</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toomes</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in TSPAN12 cause autosomal-dominant familial exudative vitreoretinopathy.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2010</year>
                <volume>86</volume>
                <fpage>248</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">20159112</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.rehm.2002.4286">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rehm</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burgess</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halpin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berger</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morton</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corey</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>ZY</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Vascular defects and sensorineural deafness in a mouse model of Norrie disease.</article-title>
                <source>J Neurosci</source>
                <volume>22</volume>
                <fpage>4286</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">12040033</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.richter.1998.2450">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Richter</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gottanka</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>May</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Welge-Lussen</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berger</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lutjen-Drecoll</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Retinal vasculature changes in Norrie disease mice.</article-title>
                <source>Invest Ophthalmol Vis Sci</source>
                <volume>39</volume>
                <fpage>2450</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9804153</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.riveiroalvarez.2005.705">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Riveiro-Alvarez</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trujillo-Tiebas</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gimenez-Pardo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia-Hoyos</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cantalapiedra</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lorda-Sanchez</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez de Alba</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramos</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ayuso</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Genotype-phenotype variations in five Spanish families with Norrie disease or X-linked FEVR.</article-title>
                <source>Mol Vis</source>
                <volume>11</volume>
                <fpage>705</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">16163268</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.robitaille.2002.326">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Robitaille</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacDonald</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaykas</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sheldahl</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeisler</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dube</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>LH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singaraja</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guernsey</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zheng</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siebert</surname>
                    <given-names>LF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoskin-Mott</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trese</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pimstone</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shastry</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moon</surname>
                    <given-names>RT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayden</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldberg</surname>
                    <given-names>YP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Samuels</surname>
                    <given-names>ME</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy.</article-title>
                <source>Nat Genet</source>
                <volume>32</volume>
                <fpage>326</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">12172548</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.rodriguezrevenga.2007.916">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rodriguez-Revenga</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Madrigal</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alkhalidi</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armengol</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonzalex</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Badenas</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Estivill</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mila</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Contiguous deletion of the NDP, MAOA, MAOBV and EFHC2 genes in a patient with Norrie disease, severe psychomotor retardation and myoclonic epilepsy.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>143A</volume>
                <fpage>916</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">17431911</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.romaniello.2013.1702">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Romaniello</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arrigoni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Citterio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonelli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sforzini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rizzari</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pessina</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Triulzi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bassi</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borgatti</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Cerebroretinal microangiopathy with calcifications and cysts associated with <italic toggle="yes">CTCI</italic> and <italic toggle="yes">NDP</italic> mutaitons.</article-title>
                <source>J Child Neurol</source>
                <volume>28</volume>
                <fpage>1702</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">23220793</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.sch_fer.2009.906">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sch&#x000e4;fer</surname>
                    <given-names>NF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luhmann</surname>
                    <given-names>UFO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feil</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berger</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Differential gene expression in Ndph-knockout mice in retinal development.</article-title>
                <source>Invest. Ophthalmol. Vis. Sci.</source>
                <volume>50</volume>
                <fpage>906</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">18978344</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.schuback.1995.285">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schuback</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>ZY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Craig</surname>
                    <given-names>IW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breakefield</surname>
                    <given-names>XO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sims</surname>
                    <given-names>KB</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Mutations in the Norrie disease gene.</article-title>
                <source>Hum Mutat</source>
                <volume>5</volume>
                <fpage>285</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">7627181</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.seitz.2010.5998">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Seitz</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hackl</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seibuchner</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamm</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohlmann</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Norrin mediates neuroprotective effects on retinal ganglion cells via activation of the Wnt/beta-catenin signaling pathway and the induction of neuroprotective growth factors in Muller cells.</article-title>
                <source>J Neurosci.</source>
                <volume>30</volume>
                <fpage>5998</fpage>
                <lpage>6010</lpage>
                <pub-id pub-id-type="pmid">20427659</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.shastry.2000.627">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shastry</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hiraoka</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trese</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <article-title>Lack of association of the Norrie disease gene with retinoschisis phenotype.</article-title>
                <source>Jpn J Ophthalmol.</source>
                <year>2000</year>
                <volume>44</volume>
                <fpage>627</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11094177</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.shastry.1997.651">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shastry</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pendergast</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hartzer</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trese</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Identification of missense mutations in the Norrie disease gene associated with advanced retinopathy of prematurity.</article-title>
                <source>Arch Ophthalmol</source>
                <volume>115</volume>
                <fpage>651</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">9152134</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.shastry.1998.35">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shastry</surname>
                    <given-names>BS</given-names>
                  </name>
                </person-group>
                <article-title>Identification of a recurrent missense mutation in the Norrie disease gene associated with a simplex case of exudative vitreoretinopathy.</article-title>
                <source>Biochem Biophys Res Commun.</source>
                <year>1998</year>
                <volume>246</volume>
                <fpage>35</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9618247</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.shastry.2009a.884">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shastry</surname>
                    <given-names>BS</given-names>
                  </name>
                </person-group>
                <article-title>Persistent hyperplastic primary vitreous: congenital malformation of the eye.</article-title>
                <source>Clin Experiment Ophthalmol.</source>
                <year>2009a</year>
                <volume>37</volume>
                <fpage>884</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">20092598</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.shastry.2009b.3">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shastry</surname>
                    <given-names>BS</given-names>
                  </name>
                </person-group>
                <article-title>SNPs: impact on gene function and phenotype.</article-title>
                <source>Methods Mol Biol.</source>
                <year>2009b</year>
                <volume>578</volume>
                <fpage>3</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">19768584</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.sims.1989.1069">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sims</surname>
                    <given-names>KB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de la Chapelle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Norio</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sankila</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hsu</surname>
                    <given-names>YP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rinehart</surname>
                    <given-names>WB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corey</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozelius</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Powell</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruns</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gusella</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murphy</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breakefield</surname>
                    <given-names>XO</given-names>
                  </name>
                </person-group>
                <year>1989</year>
                <article-title>Monoamine oxidase deficiency in males with an X chromosome deletion.</article-title>
                <source>Neuron</source>
                <volume>2</volume>
                <fpage>1069</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">2483108</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.sisk.2014.1312">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sisk</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hufnagel</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bandi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polzin</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahmed</surname>
                    <given-names>ZM</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Planned Preterm Delivery and Treament of retinal neovascularization in Norrie disease.</article-title>
                <source>Ophthalmology</source>
                <volume>121</volume>
                <fpage>1312</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">24529712</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.smallwood.2007.4057">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Smallwood</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leahy</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nathans</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Mutational analysis of Norrin-Frizzled4 recognition.</article-title>
                <source>J Biol Chem.</source>
                <volume>282</volume>
                <fpage>4057</fpage>
                <lpage>68</lpage>
                <pub-id pub-id-type="pmid">17158104</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.smith.2012.1909">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mullen</surname>
                    <given-names>TE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sims</surname>
                    <given-names>KB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rehm</surname>
                    <given-names>HL</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Norrie disease: extraocular clinical manifestations in 56 patients.</article-title>
                <source>Am J Med Genet</source>
                <volume>158A</volume>
                <fpage>1909</fpage>
                <lpage>17</lpage>
                <pub-id pub-id-type="pmid">22786811</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.staropoli.2010.786">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Staropoli</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xin</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sims</surname>
                    <given-names>KB</given-names>
                  </name>
                </person-group>
                <article-title>Co-segregation of Norrie disease and idiopathic pulmonary hypertension in a family with a microdeletion of the NDP region at Xp11.3-p11.4.</article-title>
                <source>J Med Genet.</source>
                <year>2010</year>
                <volume>47</volume>
                <fpage>786</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">20679667</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.su_rezmerino.2001.523">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Su&#x000e1;rez-Merino</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bye</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McDowall</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Craig</surname>
                    <given-names>IW</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Sequence analysis and transcript identification within 1.5 mB of DNA deleted together with the NDP and MAO genes in atypical Norrie disease patients presenting with a profound phenotype.</article-title>
                <source>Hum Mutat</source>
                <volume>17</volume>
                <fpage>523</fpage>
                <pub-id pub-id-type="pmid">11385715</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.talks.2001.e46">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Talks</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ebenezer</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hykin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adams</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulenberg</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gregory-Evans</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gregory-Evans</surname>
                    <given-names>CY</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>De novo mutations in the 5' regulatory region of the Norrie disease gene in retinopathy of prematurity.</article-title>
                <source>J Med Genet</source>
                <volume>38</volume>
                <fpage>E46</fpage>
                <pub-id pub-id-type="pmid">11748312</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.tokunaga.2013.222">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tokunaga</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>Y-H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dailey</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheng</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drenser</surname>
                    <given-names>KA</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Retinal vascular rescue of oxygen-induced retionopathy in mice by Norrin.</article-title>
                <source>Invest Ophthalmol Vis Sci.</source>
                <volume>54</volume>
                <fpage>222</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">23188723</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.toomes.2004.721">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Toomes</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bottomley</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Towns</surname>
                    <given-names>KV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackey</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Craig</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trembath</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woodruff</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gregory-Evans</surname>
                    <given-names>CY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gregory-Evans</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parker</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Black</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Downey</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inglehearn</surname>
                    <given-names>CF</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q.</article-title>
                <source>Am J Hum Genet</source>
                <volume>74</volume>
                <fpage>721</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">15024691</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.walsh.2010.456">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Walsh</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drenser</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Capone</surname>
                    <given-names>A</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Trese</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <article-title>Early vitrectomy effective for Norrie disease.</article-title>
                <source>Arch Ophthalmol.</source>
                <year>2010</year>
                <volume>128</volume>
                <fpage>456</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">20385941</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.walsh.2011.819">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Walsh</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drenser</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Capone</surname>
                    <given-names>A</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Trese</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <article-title>Norrie disease vs familial exudative vitreoretinopathy.</article-title>
                <source>Arch Ophthalmol.</source>
                <year>2011</year>
                <volume>129</volume>
                <fpage>819</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">21670366</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.wang.2012.1332">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rattner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smallwood</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nathans</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Norrin/Frizzled4 signaling in retinal vascular development and blood brain barrier plasticity.</article-title>
                <source>Cell</source>
                <volume>151</volume>
                <fpage>1332</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">23217714</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.warden.2007.211">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Warden</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andreoli</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mukai</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>The Wnt signaling pathway in familial exudative vitreoretinopathy and Norrie disease.</article-title>
                <source>Semin Ophthalmol</source>
                <volume>22</volume>
                <fpage>211</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">18097984</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.wu.2007.225">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>W-C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drenser</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trese</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Capone</surname>
                    <given-names>A</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Dailey</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Retinal phenotype-genotype correlation of pediatric patients expressing mutations in the Norrie disease gene.</article-title>
                <source>Arch Ophthalmol.</source>
                <volume>125</volume>
                <fpage>225</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">17296899</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.xu.2004.883">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dabdoub</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smallwood</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woods</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelley</surname>
                    <given-names>MW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tasman</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nathans</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair.</article-title>
                <source>Cell</source>
                <volume>116</volume>
                <fpage>883</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">15035989</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.yamada.2001.52">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Limprasert</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ratanasukon</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tengtrisorn</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yingchareonpukdee</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasiknanonte</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kitaoka</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghadami</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niikawa</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kishino</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Two Thai families with Norrie disease (ND): association of two novel missense mutations with severe ND phenotype, seizures, and a manifesting carrier.</article-title>
                <source>Am J Med Genet</source>
                <volume>100</volume>
                <fpage>52</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">11337749</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.yang.2012.726">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xiao</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guo</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhange</surname>
                    <given-names>Q</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Screening for DNP mutations in 44 unrelated pateints with familial exudative vitreoretinopathy or Norrie disease.</article-title>
                <source>Curr Eye Res.</source>
                <volume>37</volume>
                <fpage>726</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">22563645</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.yang.2011.1128">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xiao</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mai</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhange</surname>
                    <given-names>Q</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Novel <italic toggle="yes">TSPAN12</italic> mutations in patients with familial exudative vitroretionopathy and their associated phenotypes.</article-title>
                <source>Mol Vis</source>
                <volume>17</volume>
                <fpage>1128</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">21552475</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.ye.2011.151">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ye</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smallwood</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nathans</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Expression of the Norrie disease gene (<italic toggle="yes">Ndp</italic>) in developing and adult mouse eye, ear, and brain.</article-title>
                <source>Gene Expr Patterns</source>
                <volume>11</volume>
                <fpage>151</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">21055480</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.ye.2010.417">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ye</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nathans</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>The Norrin/Frizzled4 signaling pathway in retinal vascular development and disease.</article-title>
                <source>Trends Mol Med.</source>
                <volume>16</volume>
                <fpage>417</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">20688566</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.zaremba.1998.157">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zaremba</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feil</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Juszko</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myga</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Duijnhoven</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berger</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Intrafamilial variability of the ocular phenotype in a Polish family with a missense mutation (A63D) in the Norrie disease gene.</article-title>
                <source>Ophthalmic Genet</source>
                <volume>19</volume>
                <fpage>157</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">9810571</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.zhang.2011.10210">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harada</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wei</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shukla</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajendran</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tawansy</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bedell</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lim</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw</surname>
                    <given-names>PX</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>Z</given-names>
                  </name>
                </person-group>
                <article-title>An essential role of the cysteine-rich domain of FZD4 in Norrin/Wnt signaling and familial exudative vitreoretinopathy.</article-title>
                <source>J Biol Chem.</source>
                <year>2011</year>
                <volume>286</volume>
                <fpage>10210</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">21177847</pub-id>
              </element-citation>
            </ref>
            <ref id="norrie.REF.zhang.2013.739">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>XY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>WY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>SQ</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>A novel Norrie disease pseudoglioma gene mutation, c.-1_2delAAT, responsible for Norrie disease in a Chinese family.</article-title>
                <source>Int J Ophthalmol.</source>
                <volume>6</volume>
                <fpage>739</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">24392318</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="norrie.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="norrie.Suggested_Reading.reflist0">
            <ref id="norrie.REF.berger">
              <mixed-citation publication-type="webpage">Berger W, Ropers HH. Norrie disease. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G, eds. <italic toggle="yes">The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID)</italic>. Chap 239. McGraw-Hill. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://ommbid.mhmedical.com/">online</ext-link>. Accessed 5-11-16.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="norrie.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="norrie.Author_Notes">
          <title>Author Notes</title>
          <p>Web: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.dnalab.org/">www.DNAlab.org</ext-link></p>
        </sec>
        <sec id="norrie.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>18 September 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>23 July 2009 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>8 August 2006 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>14 May 2004 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>11 June 2002 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>30 July 1999 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>10 February 1999 (ks) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="norrie.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Hearing loss in males with Norrie disease. A subset of males enrolled in the Norrie Disease Registry (n=56) by age group with hearing loss [<xref ref-type="bibr" rid="norrie.REF.smith.2012.1909">Smith et al 2012</xref>]</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="norrie-Image001" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="norrie.F2" orientation="portrait">
          <label>Figure 2. </label>
          <caption>
            <p>Peripheral vascular disease in males with Norrie disease. Peripheral vascular disease by age group in a subset of patients enrolled in the Norrie Disease Registry (n=56) [<xref ref-type="bibr" rid="norrie.REF.smith.2012.1909">Smith et al 2012</xref>]</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="norrie-Image002" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
